Chongqing Zhifei Biological Launches Phase I Clinical Trial for Group B Meningococcal Vaccine
Chongqing Zhifei Biological Co., Ltd (SHE: 300122) has announced the commencement of a Phase I...
Chipscreen Pharmaceutical’s Epidaza Granted Priority Status for DLBCL Treatment in China
The Center for Drug Evaluation (CDE) website has announced that Shenzhen Chipscreen Biosciences Co., Ltd’s...
HutchMed’s Elunate-Tyvyt Combo Receives Breakthrough Therapy Designation in China for Endometrial Cancer
HutchMed (China) Ltd (NASDAQ: HCM, HKG: 0013) has announced that the combination of Elunate (fruquintinib)...
Kintor Pharmaceutical Initiates Long-Term Safety Trial for Androgenetic Alopecia Treatment KX-826
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced the start of the long-term safety trial...
Hybribio Ltd and United Imaging Healthcare Form Strategic Partnership to Advance Medical Technology
Guangdong-based Hybribio Ltd (SHE: 300639), a leading provider of nucleic acid molecular diagnostic products, has...
Novomics Partners with TopGene to Expand Genomic Testing Services in China
South Korea-based molecular diagnostics firm Novomics Co. has announced a strategic partnership with China-based Hubei...
Stemirna Therapeutics Halts mRNA Vaccine Factory Construction Amid Low Demand
China-based Stemirna Therapeutics Co., Ltd has decided to halt the construction of a factory intended...
BGI Genomics Partners with Thai Entities to Combat Thalassemia through Genomics and Cell Therapy
China-based genomics leader BGI Genomics Co., Ltd (SHE: 300676) has entered into a memorandum of...
Shanghai Junshi Biosciences’ Tuoyi Receives NMPA Review for ES-SCLC Treatment
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced that the National Medical...
Sichuan Gowell Pharmaceutical Wins Reversal in Forxiga Patent Infringement Case
Sichuan Gowell Pharmaceutical Co., Ltd. has secured a favorable final judgment in its appeal against...
Boyu Capital Acquires Hong Kong Medical Device Company Quasar for Over $600 Million
Boyu Capital, according to a Bloomberg report, is set to acquire Quasar, a Hong Kong-based...
Novartis Q2 2023 Results Exceed Expectations with 9% YOY Sales Growth
Swiss pharmaceutical major Novartis AG (NYSE: NVS) has reported its financial results for the second...
Shanghai Pharmaceuticals and Mindray Form Strategic Alliance for Medical Equipment and IVD Products
Shanghai Pharmaceuticals (SHA: 601607, HKG: 2607), a leading pharmaceutical company in China, has announced a...
MindRank Ltd Secures Over $20 Million in Series A+ Funding to Advance AI Drug Development
China-based artificial intelligence (AI)-enabled drug developer MindRank Ltd has reportedly secured more than USD 20...
Zhejiang Dian Diagnostics Partners with Northeast Infectious Diseases Alliance to Enhance Surveillance
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading diagnostics specialist based in China, has...
Novartis Acquires DTx Pharma and Its FALCON Technology for Up to $1 Billion
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced the acquisition of DTx Pharma Inc., a...
Allen Institute for Immunology Partners with Eli Lilly to Study Atopic Dermatitis and Rheumatoid Arthritis
The US-based Allen Institute for Immunology has announced a strategic partnership with compatriot company Eli...
Pfizer and Flagship Pioneering Invest $100 Million in Drug Candidates Development
Global pharmaceutical giant Pfizer (NYSE: PFE) and venture capital firm Flagship Pioneering have this week...
Qihan Biotech’s QN-019a Receives Clinical Clearance for Gene-Edited iPSC-Derived Cell Therapy in China
Hangzhou Qihan Biotech Co., Ltd., a leading specialist in xenotransplantation based in China, has announced...
Major Pharma Companies Pledge Support for 250,000 Genomes Sequencing Project
This week, leading pharmaceutical companies AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), AstraZeneca (AZ; NASDAQ: AZN),...